Covered recipient · General Payments record
RONALD HEINE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,266.83
- Reported across 303 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $642.58 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $276.60 | 9 |
| Novo Nordisk AS | $159.07 | 11 |
| Lilly USA, LLC | $61.36 | 4 |
| Lundbeck LLC | $23.90 | 1 |
| Astellas Pharma US Inc | $23.47 | 1 |
| Insulet Corporation | $18.88 | 1 |
| Exact Sciences Corporation | $18.12 | 1 |
| Amgen Inc. | $16.77 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.36 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.89 | 1 |
| Acerta Pharma LLC | $14.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117576142 | CMS |
| Astellas Pharma US Inc | $23.47 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139431852 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.16 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104277335 | CMS |
| Exact Sciences Corporation | $18.12 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114697931 | CMS |
| Insulet Corporation | $18.88 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116812405 | CMS |
| Lilly USA, LLC | $15.42 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135365518 | CMS |
| Lilly USA, LLC | $14.39 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135402625 | CMS |
| Lilly USA, LLC | $15.66 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135339304 | CMS |
| Lilly USA, LLC | $15.89 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135402623 | CMS |
| Lundbeck LLC | $23.90 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145924236 | CMS |
| Novo Nordisk Inc | $11.45 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096655640 | CMS |
| Novo Nordisk Inc | $11.34 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097779653 | CMS |
| Novo Nordisk Inc | $17.16 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097446775 | CMS |
| Novo Nordisk Inc | $14.00 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096887220 | CMS |
| Novo Nordisk Inc | $11.10 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096821413 | CMS |
| Novo Nordisk Inc | $21.33 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096721545 | CMS |
| Novo Nordisk Inc | $12.51 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096673803 | CMS |
| Novo Nordisk Inc | $23.12 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097198098 | CMS |
| Novo Nordisk Inc | $12.34 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097489618 | CMS |
| Novo Nordisk Inc | $5.81 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097111887 | CMS |
| Novo Nordisk Inc | $18.91 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097318205 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.36 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118907335 | CMS |
| PFIZER INC. | $3.11 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131407437 | CMS |
| PFIZER INC. | $126.20 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131343363 | CMS |
| PFIZER INC. | $10.95 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131369488 | CMS |
| PFIZER INC. | $2.48 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131503642 | CMS |
| PFIZER INC. | $10.84 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131756210 | CMS |
| PFIZER INC. | $11.27 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131877196 | CMS |
| PFIZER INC. | $5.74 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131945604 | CMS |
| PFIZER INC. | $1.16 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131964807 | CMS |
| PFIZER INC. | $104.85 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131049939 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.89 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151071292 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.